Remdesivir (GS-5734) as a therapeutic option of 2019-nCOV main protease – in silico approach

References

• Agostini, M. L., Andres, E. L., Sims, A. C., Graham, R. L., Sheahan, T. P., Lu, X., Smith, E. C., Case, J. B., Feng, J. Y., Jordan, R., Ray, A. S., Cihlar, T., Siege, l D., Mackman, R. L., Clarke, M. O., Baric, R. S., & Denison, M. R. (2018). Coronavirus susceptibility to the antiviral remdesivir (GS-5734) is mediated by the viral polymerase and the proofreading exoribonuclease. mBio, 9(2), 1–15. https://doi.org/10.1128/mBio.00221-18
   Web of Science ®Google Scholar
• Anand, K., Ziebuhr, J., Wadhwani, P., Mesters, J. R., & Hilgenfeld, R. (2003). Coronavirus main proteinase (3CLpro) structure: Basis for design of anti-SARS drugs. Science (New York, N.Y.).), 300(5626), 1763–1767. https://doi.org/10.1126/science.1085658
   PubMed Web of Science ®Google Scholar
• Azam, S. S., & Abbasi, S. W. (2013). Molecular docking studies for the identification of novel melatoninergic inhibitors for acetylserotonin-O-methyltransferase using different docking routines. Theoretical Biology & Medical Modelling, 10(1), 63. https://doi.org/10.1186/1742-4682-10-63
   PubMed Web of Science ®Google Scholar
• Boopathi, S., Poma, A. B., & Kolandaivel, P. (2020). Novel 2019 coronavirus structure, mechanism of action, antiviral drug promisesand rule out against it treatment. Journal of Biomolecular Structure and Dynamics, 1–4. https://doi.org/10.1080/07391102.2020.1758788
   Google Scholar
• Cai, Q., Yang, M., Liu, D., Chen, J., Shu, D., Xia, J., Liao, X., Gu, Y., Cai, Q., Yang, Y., Shen, C., Li, X., Peng, L., Huang, D., Zhang, J., Zhang, S., Wang, F., Liu, J., Chen, L., … Liu, L. (2020). Experimental treatment with favipiravir for COVID-19: An open-label control study. Engineering. [In press]. https://doi.org/10.1016/j.eng.2020.03.007
   Web of Science ®Google Scholar
• Chen, J. (2020). Pathogenicity and transmissibility of 2019-nCoV-A quick overview and comparison with other emerging viruses. Microbes and Infection, 22(2), 69–71. https://doi.org/10.1016/j.micinf.2020.01.004
   PubMed Web of Science ®Google Scholar
• Elfiky, A. A. (2020). Natural products may interfere with SARS-CoV-2 attachment to the host cell. Journal of Biomolecular Structure and Dynamics, 1–16. https://doi.org/10.1080/07391102.2020.1761881
   Web of Science ®Google Scholar
• Felsenstein, J. (1985). Confidence limits on phylogenies: An approach using the bootstrap. Evolution; International Journal of Organic Evolution, 39(4), 783–791. https://doi.org/10.1111/j.1558-5646.1985.tb00420.x
   PubMed Web of Science ®Google Scholar
• Harrison, C. (2020). Coronavirus puts drug repurposing on the fast track. Nature Biotechnology, 38(4), 379–381. https://doi.org/10.1038/d41587-020-00003-1
   PubMed Web of Science ®Google Scholar
• Hasan, A., Paray, B. A., Hussain, A., Qadir, F. A., Attar, F., & Aziz, F. M. (2020). A review on the cleavage priming of the spike protein on coronavirus by angiotensin-converting enzyme-2 and furin. Journal of Biomolecular Structure and Dynamics, 1–9.
   PubMed Web of Science ®Google Scholar
• Hay, A. J., Gregory, V., Douglas, A. R., & Lin, Y. P. (2001). The evolution of human influenza viruses. Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences, 356(1416), 1861–1870. https://doi.org/10.1098/rstb.2001.0999
   PubMed Web of Science ®Google Scholar
• Higgins, D. G., & Sharp, P. M. (1988). CLUSTAL: A package for performing multiple sequence alignment on a microcomputer. Gene, 73(1), 237–244. https://doi.org/10.1016/0378-1119(88)90330-7 https://doi.org/10.1016/0378-1119(88)90330-7
   PubMed Web of Science ®Google Scholar
• Hilgenfeld, R. (2014). From SARS to MERS: Crystallographic studies on coronaviral proteases enable antiviral drug design. The FEBS Journal, 281(18), 4085–4096. https://doi.org/10.1111/febs.12936
   PubMed Web of Science ®Google Scholar
• Holshue, M. L., DeBolt, C., Lindquist, S., Lofy, K. H., Wiesman, J., Bruce, H., Spitters, C., Ericson, K., Wilkerson, S., Tural, A., Diaz, G., Cohn, A., Fox, L., Patel, A., Gerber, S. I., Kim, L., Tong, S., Lu, X., Lindstrom, S., … Pillai, S. K. (2020). First case of 2019 novel coronavirus in the United States. The New England Journal of Medicine, 382(10), 929–936. https://doi.org/10.1056/NEJMoa2001191
   PubMed Web of Science ®Google Scholar
• Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., Zhang, L., Fan, G., Xu, J., Gu, X., Cheng, Z., Yu, T., Xia, J., Wei, Y., Wu, W., Xie, X., Yin, W., Li, H., Liu, M., … Cao, B. (2020). Clinical features of patients infected with 2019 novel coronavirus in Wuhan. The Lancet, 395(10223), 497–506. https://doi.org/10.1016/S0140-6736(20)30183-5
   PubMed Web of Science ®Google Scholar
• Jin, Z., Du, X., Xu, Y., Deng, Y., Liu, M., Zhao, Y., Zhang, B., Li, X., Zhang, L., Peng, C., Duan, Y., Yu, J., Wang, L., Yang, K., Liu, F., Jiang, R., Yang, X., You, T., Liu, X., … Yang, H. (2020). Structure of Mpro from COVID-19 virus and discovery of its inhibitors. Nature, 582(7811), 289–293. https://doi.org/10.1038/s41586-020-2223-y
   PubMed Web of Science ®Google Scholar
• Jordan, P. C., Liu, C., Raynaud, P., Lo, M. K., Spiropoulou, C. F., Symons, J. A., Beigelman, L., & Deval, J. (2018). Initiation, extension, and termination of RNA synthesis by a paramyxovirus polymerase. PLoS Pathogens, 14(2), e1006889. https://doi.org/10.1371/journal.ppat.1006889
   PubMed Web of Science ®Google Scholar
• Khandare, A. L., Validandi, V., Manne, M., Reddy, G. B., Kumar Putcha, U., & Gourineni, S. R. (2018). Tamarind fruit extract ameliorates fluoride toxicity by upregulating carbonic anhydrase II: A mechanistic study. Fluoride, 51(2), 137–152.
   Web of Science ®Google Scholar
• Killerby, M. E., Biggs, H. M., Haynes, A., Dahl, R. M., Mustaquim, D., Gerber, S. I., & Watson, J. T. (2018). Human coronavirus circulation in the United States 2014–2017. Journal of Clinical Virology, 101, 52–56. https://doi.org/10.1016/j.jcv.2018.01.019
   PubMed Web of Science ®Google Scholar
• Kumar, B., Asha, K., Khanna, M., Ronsard, L., Meseko, C. A., & Sanicas, M. (2018). The emerging influenza virus threat: Status and new prospects for its therapy and control. Archives of Virology, 163(4), 831–844. https://doi.org/10.1007/s00705-018-3708-y
   PubMed Web of Science ®Google Scholar
• Kumar, S., Stecher, G., Li, M., Knyaz, C., & Tamura, K. (2018). MEGA X: Molecular evolutionary genetics analysis across computing platforms. Molecular Biology and Evolution, 35(6), 1547–1549. https://doi.org/10.1093/molbev/msy096
   PubMed Web of Science ®Google Scholar
• Lee, T. W., Cherney, M. M., Huitema, C., Liu, J., James, K. E., Powers, J. C., Eltis, L. D., & James, M. N. G. (2005). Crystal structures of the main peptidase from the SARS coronavirus inhibited by a substrate-like aza-peptide epoxide. Journal of Molecular Biology, 353(5), 1137–1151. https://doi.org/10.1016/j.jmb.2005.09.004
   PubMed Web of Science ®Google Scholar
• Leimkuhler, B. J., & Sweet, C. R. (2004). The canonical ensemble via symplectic integrators using Nosé and Nosé-Poincaré chains. The Journal of Chemical Physics, 121(1), 108–116. https://doi.org/10.1063/1.1740753
   PubMed Web of Science ®Google Scholar
• Lu, H. (2020). Drug treatment options for the 2019-new coronavirus (2019-nCoV). Bioscience Trends, 14(1), 69–71. https://doi.org/10.5582/bst.2020.01020
   PubMed Web of Science ®Google Scholar
• Luytjes, W., Bredenbeek, P. J., Noten, A. F. H., Horzinek, M. C., & Spaan, W. J. M. (1988). Sequence of mouse hepatitis virus A59 mRNA 2: Indications for RNA recombination between coronaviruses and influenza C virus. Virology, 166(2), 415–422. https://doi.org/10.1016/0042-6822(88)90512-0 https://doi.org/10.1016/0042-6822(88)90512-0
   PubMed Web of Science ®Google Scholar
• Lu, R., Zhao, X., Li, J., Niu, P., Yang, B., Wu, H., Wang, W., Song, H., Huang, B., Zhu, N., Bi, Y., Ma, X., Zhan, F., Wang, L., Hu, T., Zhou, H., Hu, Z., Zhou, W., Zhao, L., … Tan, W. (2020). Genomic characterisation and epidemiology of 2019 novel coronavirus: Implications for virus origins and receptor binding. The Lancet, 395(10224), 565–574. https://doi.org/10.1016/S0140-6736(20)30251-8 https://doi.org/10.1016/S0140-6736(20)30251-8
   PubMed Web of Science ®Google Scholar
• Medhi, B., Prajapat, M., Sarma, P., Shekhar, N., Avti, P., Sinha, S., Kaur, H., Kumar, S., Bhattacharyya, A., Kumar, H., & Bansal, S. (2020). Drug targets for corona virus: A systematic review. Indian Journal of Pharmacology, 52(1), 56–65. https://doi.org/10.4103/ijp.IJP_115_20
   PubMed Web of Science ®Google Scholar
• Morris, G. M., Ruth, H., Lindstrom, W., Sanner, M. F., Belew, R. K., Goodsell, D. S., & Olson, A. J. (2009). Software news and updates AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility. Journal of Computational Chemistry, 30(16), 2785–2791. https://doi.org/10.1002/jcc.21256
   PubMed Web of Science ®Google Scholar
• Munikumar, M., Natarajan, P., Amineni, U., & Radha Krishna, K. V. (2019). Discovery of potential lumazine synthase antagonists for pathogens involved in bacterial meningitis: In silico study. Informatics in Medicine Unlocked, 15, 100187. https://doi.org/10.1016/j.imu.2019.100187
   Google Scholar
• Pant, S., Singh, M., Ravichandiran, V., Murty, U. S. N., & Srivastava, H. K. (2020). Peptide-like and small-molecule inhibitors against Covid-19. Journal of Biomolecular Structure and Dynamics, 1–15. https://doi.org/10.1080/07391102.2020.1757510
   Google Scholar
• Pradhan, D., Priyadarshini, V., Munikumar, M., Swargam, S., Umamaheswari, A., & Bitla, A. (2014). Para-(benzoyl)-phenylalanine as a potential inhibitor against LpxC of Leptospira spp.: Homology modeling, docking, and molecular dynamics study. Journal of Biomolecular Structure & Dynamics, 32(2), 171–185. https://doi.org/10.1080/07391102.2012.758056
   PubMed Web of Science ®Google Scholar
• Rathi, S., Ish, P., Kalantri, A., & Kalantri, S. (2020). Hydroxychloroquine prophylaxis for COVID-19 contacts in India. Lancet Infectious Diseases. [In press]. https://doi.org/10.1016/S1473-3099(20)30313-3
   Google Scholar
• Sheahan, T. P., Sims, A. C., Leist, S. R., Schäfer, A., Won, J., Brown, A. J., Montgomery, S. A., Hogg, A., Babusis, D., Clarke, M. O., Spahn, J. E., Bauer, L., Sellers, S., Porter, D., Feng, J. Y., Cihlar, T., Jordan, R., Denison, M. R., & Baric, R. S. (2020). Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV. Nature Communications, 11(1), 222. https://doi.org/10.1038/s41467-019-13940-6
   PubMed Web of Science ®Google Scholar
• Siegel, D., Hui, H. C., Doerffler, E., Clarke, M. O., Chun, K., Zhang, L., Neville, S., Carra, E., Lew, W., Ross, B., Wang, Q., Wolfe, L., Jordan, R., Soloveva, V., Knox, J., Perry, J., Perron, M., Stray, K. M., Barauskas, O., … Mackman, R. L. (2017). Discovery and synthesis of a phosphoramidate prodrug of a pyrrolo[2,1-f][triazin-4-amino] adenine C-nucleoside (GS-5734) for the treatment of Ebola and emerging viruses. Journal of Medicinal Chemistry, 60(5), 1648–1661. https://doi.org/10.1021/acs.jmedchem.6b01594
   PubMed Web of Science ®Google Scholar
• Sliwoski, G., Kothiwale, S., Meiler, J., & Lowe, E. W. (2014). Computational methods in drug discovery. Pharmacological Reviews, 66(1), 334–395. https://doi.org/10.1124/pr.112.007336
   PubMed Web of Science ®Google Scholar
• Tchesnokov, E. P., Feng, J. Y., Porter, D. P., & Gotte, M. (2019). Mechanism of inhibition of Ebola virus RNA-dependent RNA polymerase by remdesivir. Viruses, 11(4), 326. https://doi.org/10.3390/v11040326
   PubMed Web of Science ®Google Scholar
• Ton, A.-T., Gentile, F., Hsing, M., Ban, F., & Cherkasov, A. (2020). Rapid identification of potential inhibitors of SARS‐CoV‐2 main protease by deep docking of 1.3 billion compounds. Molecular Informatics, 39, 2000028. https://doi.org/10.1002/minf.202000028
   Google Scholar
• Umamaheswari, A., Kumar, M. M., Pradhan, D., & Marisetty, H. (2011). Docking studies towards exploring antiviral compounds against envelope protein of yellow fever virus. Interdisciplinary Sciences, Computational Life Sciences, 3(1), 64–77. https://doi.org/10.1007/s12539-011-0064-y
   PubMed Web of Science ®Google Scholar
• Vilar, S., Karpiak, J., Berk, B., & Costanzi, S. (2011). In silico analysis of the binding of agonists and blockers to the β2-adrenergic receptor. Journal of Molecular Graphics & Modelling, 29(6), 809–817. https://doi.org/10.1016/j.jmgm.2011.01.005
   PubMed Web of Science ®Google Scholar
• Vincent, M. J., Bergeron, E., Benjannet, S., Erickson, B. R., Rollin, P. E., Ksiazek, T. G., Seidah, N. G., & Nichol, S. T. (2005). Chloroquine is a potent inhibitor of SARS coronavirus infection and spread. Virology Journal, 2(1), 69. https://doi.org/10.1186/1743-422X-2-69
   PubMed Web of Science ®Google Scholar
• Wang, M., Cao, R., Zhang, L., Yang, X., Liu, J., Xu, M., Shi, Z., Hu, Z., Zhong, W., & Xiao, G. (2020). Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro. Cell Research, 30(3), 269–271. https://doi.org/10.1038/s41422-020-0282-0
   PubMed Web of Science ®Google Scholar
• Yang, Y., Peng, F., Wang, R., Guan, K., Jiang, T., Xu, G., Sun, J., & Chang, C. (2020). The deadly coronaviruses: The 2003 SARS pandemic and the 2020 novel coronavirus epidemic in China. Journal of Autoimmunity, 109, 102434. https://doi.org/10.1016/j.jaut.2020.102434
   PubMed Web of Science ®Google Scholar
• Yu, F., Du, L., Ojcius, D. M., Pan, C., & Jiang, S. (2020). Measures for diagnosing and treating infections by a novel coronavirus responsible for a pneumonia outbreak originating in Wuhan, China. Microbes and Infection, 22(2), 74–79. https://doi.org/10.1016/j.micinf.2020.01.003
   PubMed Web of Science ®Google Scholar
• Zhang, L., Lin, D., Sun, X., Curth, U., Drosten, C., Sauerhering, L., Becker, S., Rox, K., & Hilgenfeld, R. (2020). Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved α-ketoamide inhibitors. Science (New York, N.Y.).), 368(6489), 409–412. https://doi.org/10.1126/science.abb3405
   PubMed Web of Science ®Google Scholar
• Zhu, N., Zhang, D., Wang, W., Li, X., Yang, B., Song, J., Zhao, X., Huang, B., Shi, W., Lu, R., Niu, P., Zhan, F., Ma, X., Wang, D., Xu, W., Wu, G., Gao, G. F., & Tan, W. (2020). A novel coronavirus from patients with pneumonia in China, 2019. New England Journal of Medicine, 382(8), 727–733. https://doi.org/10.1056/NEJMoa2001017
   PubMed Web of Science ®Google Scholar